{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:34:28Z","timestamp":1780446868020,"version":"3.54.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"crossref","award":["Junior Clinical Investigator Award"],"award-info":[{"award-number":["Junior Clinical Investigator Award"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Mutations of the v-Raf murine sarcoma viral oncogene homolog B <jats:italic toggle=\"yes\">(BRAF)<\/jats:italic> oncogene and telomerase reverse transcriptase (<jats:italic toggle=\"yes\">TERT<\/jats:italic>) promoter region are indicators of poor prognosis in papillary thyroid carcinoma (PTC) and might predict future occurrences of distant metastases. However, the clinical significance of these genetic aberrancies in PTCs arising in ectopic locations is not well established.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We describe a patient with a previous history of radioiodine (RAI)-treated hyperthyroidism and a surgically resected right-sided follicular thyroid adenoma. In 2013, a 6\u200amm follicular variant papillary thyroid carcinoma was diagnosed following a left-sided thyroid lobectomy. The central compartment displayed 9 tumor-free lymph nodes, and no adjuvant treatment was planned.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Three years later, a 26\u200amm pre-tracheal relapse was noted, however, the excised lesion was consistent with a tall cell variant of papillary thyroid carcinoma (TCV-PTC) arising in ectopic thyroid tissue. RAI treatment was commenced. Four years later, a 5\u200amm subcutaneous lesion in the anterior neck was surgically removed and diagnosed as metastatic TCV-PTC with a codon 600 <jats:italic toggle=\"yes\">BRAF<\/jats:italic> mutation and a C228T <jats:italic toggle=\"yes\">TERT<\/jats:italic> promoter mutation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>RAI treatment was re-initiated. Molecular re-examination of the primary follicular variant papillary thyroid carcinoma demonstrated a codon 600 <jats:italic toggle=\"yes\">BRAF<\/jats:italic> mutation and a <jats:italic toggle=\"yes\">TERT<\/jats:italic> promoter wildtype sequence, while the primary TCV-PTC was positive for mutations in both codon 600 of <jats:italic toggle=\"yes\">BRAF<\/jats:italic> as well as the <jats:italic toggle=\"yes\">TERT<\/jats:italic> promoter.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient is alive and well without signs of relapse 7\u200amonths after the latest round of RAI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We conclude that the occurrence of combined <jats:italic toggle=\"yes\">BRAF<\/jats:italic> and <jats:italic toggle=\"yes\">TERT<\/jats:italic> promoter mutations in the primary lesion from 2016 was associated to the manifestation of distant metastases 4 years later, strengthening the benefit of mutational screening of these genes in clinical routine for thyroid carcinomas arising in aberrant locations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024237","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T16:11:44Z","timestamp":1610640704000},"page":"e24237","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue"],"prefix":"10.1097","volume":"100","author":[{"given":"Adam","family":"Stenman","sequence":"first","affiliation":[{"name":"Department of Oncology-Pathology"},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet"},{"name":"Department of Breast, Endocrine Tumors and Sarcoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Koman","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet"},{"name":"Department of Breast, Endocrine Tumors and Sarcoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Ihre-Lundgren","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet"},{"name":"Department of Breast, Endocrine Tumors and Sarcoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-9081","authenticated-orcid":false,"given":"Carl Christofer","family":"Juhlin","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology"},{"name":"Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0030-6665(20)32302-1","article-title":"Thyroglossal duct and ectopic thyroid disorders","volume":"14","author":"Noyek","year":"1981","journal-title":"Otolaryngol Clin North Am"},{"issue":"(Suppl 1)","key":"R2-20250504","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijsu.2015.12.043","article-title":"Prevalence, diagnosis and management of ectopic thyroid glands","volume":"28","author":"Santangelo","year":"2016","journal-title":"Int J Surg"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/000348949610501212","article-title":"Thyroid gland ectopias","volume":"105","author":"Batsakis","year":"1996","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1210\/jc.2011-0611","article-title":"Clinical review: ectopic cervical thyroid carcinoma--review of the literature with illustrative case series","volume":"96","author":"Klubo-Gwiezdzinska","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1385\/EP:13:4:353","article-title":"Poorly differentiated oxyphilic (H\u00fcrthle cell) carcinoma arising in lingual thyroid: a case report and review of the literature","volume":"13","author":"Seoane","year":"2002","journal-title":"Endocr Pathol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/cancers11101443","article-title":"Clinical routine TERT promoter mutational screening of follicular thyroid tumors of uncertain malignant potential (FT-UMPs): a useful predictor of metastatic disease","volume":"11","author":"Hysek","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2018.12.003","article-title":"TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma","volume":"108","author":"Bournaud","year":"2019","journal-title":"Eur J Cancer"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"E1562","DOI":"10.1210\/jc.2013-2383","article-title":"Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease","volume":"98","author":"Landa","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J Clin Oncol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"E632","DOI":"10.1210\/jc.2014-3606","article-title":"Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer","volume":"100","author":"Shi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/MLG.0b013e31812e0160","article-title":"Lingual thyroid carcinoma with nodal metastasis","volume":"117","author":"Kennedy","year":"2007","journal-title":"Laryngoscope"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1089\/10507250152741055","article-title":"Lingual thyroid carcinoma: a case report and review of the literature","volume":"11","author":"Massine","year":"2001","journal-title":"Thyroid"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.6004\/jnccn.2018.0089","article-title":"NCCN guidelines insights: thyroid carcinoma, version 2.2018","volume":"16","author":"Haddad","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1158\/1078-0432.CCR-11-1155","article-title":"Role of BRAF in thyroid oncogenesis","volume":"17","author":"Caronia","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jclinpath-2018-205653","article-title":"TERT gene: its function and dysregulation in cancer","volume":"72","author":"Colebatch","year":"2019","journal-title":"J Clin Pathol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/ERC-15-0057","article-title":"Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT","volume":"22","author":"Dettmer","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/cyt.12493","article-title":"Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy","volume":"28","author":"Decaussin-Petrucci","year":"2017","journal-title":"Cytopathology"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/thy.2018.0733","article-title":"Afirma gene sequencing classifier compared with gene expression classifier in indeterminate thyroid nodules","volume":"29","author":"Endo","year":"2019","journal-title":"Thyroid"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cncy.22112","article-title":"Clinical validation of the ThyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology","volume":"127","author":"Nikiforov","year":"2019","journal-title":"Cancer Cytopathol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12022-018-9551-6","article-title":"TERT immunohistochemistry is a poor predictor of TERT promoter mutations and gene expression in follicular thyroid carcinoma","volume":"29","author":"Paulsson","year":"2018","journal-title":"Endocr Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:24:29Z","timestamp":1746339869000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024237"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024237","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"2020-09-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}